Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Charles River Laboratories International Inc CRL

Technology Scientific & Technical Instruments
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its... see more

Recent & Breaking News (NYSE:CRL)

Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development With Digital Pathology

Business Wire March 30, 2020

Charles River Laboratories To Participate In Barclays Global Healthcare Conference

Business Wire March 10, 2020

Charles River Laboratories Adds Nancy C. Andrews, M.D., Ph.D., to Board of Directors

Business Wire March 4, 2020

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2019 Results and Provides 2020 Guidance

Business Wire February 11, 2020

Charles River Laboratories Schedules Fourth-Quarter 2019 Earnings and 2020 Guidance Release and Conference Call

Business Wire January 21, 2020

Charles River Laboratories and Fios Genomics Form a Strategic Alliance to Provide Bioinformatics-driven Drug Discovery and Safety Assessment

Business Wire January 16, 2020

Charles River and Takeda Announce Scientific Collaboration to Identify and Develop Preclinical Candidates

Business Wire January 13, 2020

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

Business Wire January 13, 2020

Charles River Laboratories Completes the Acquisition of HemaCare Corporation

Business Wire January 3, 2020

SHAREHOLDER ALERT: WeissLaw LLP Investigates HemaCare Corporation

PR Newswire December 18, 2019

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HemaCare Corporation

PR Newswire December 16, 2019

Charles River Laboratories to Acquire HemaCare Corporation

Business Wire December 16, 2019

Charles River Announces Strategic Partnership with Bit Bio, Increasing Portfolio of Translational Drug Discovery Technologies

Business Wire December 10, 2019

Distributed Bio Launches Cosmic Antibody Library, Provides Charles River Clients Exclusive Access

Business Wire December 9, 2019

Charles River Laboratories Updates Tumor Model Compendium

Business Wire December 4, 2019

Charles River Laboratories to Present at Upcoming Investor Conferences

Business Wire November 11, 2019

Charles River Laboratories Announces Third-Quarter 2019 Results

Business Wire November 6, 2019

Charles River Laboratories Announces Closing of Senior Notes Offering

Business Wire October 23, 2019

Charles River Laboratories Schedules Third-Quarter 2019 Earnings Release and Conference Call

Business Wire October 21, 2019

Charles River Laboratories Announces Offering of $500 Million of Senior Notes

Business Wire October 21, 2019